Camp4 Therapeutics (CAMP) Accumulated Expenses (2023 - 2026)

Camp4 Therapeutics (CAMP) has 4 years of Accumulated Expenses data on file, last reported at $4.3 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 134.06% year-over-year to $4.3 million; the trailing twelve-month figure through Mar 2026 stood at $4.3 million (up 134.06% YoY), and the FY2025 full-year result was $5.7 million, up 17.09% from the prior year.
• Accumulated Expenses eased to $4.3 million in Q1 2026, from $5.7 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $5.7 million in Q4 2025 to a low of $1.8 million in Q1 2025.
• A 4-year average of $3.8 million and a median of $3.9 million in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses grew 10.55% in 2025 and surged 134.06% in 2026, its largest moves.
• Tracing CAMP's Accumulated Expenses over 4 years: stood at $3.3 million in 2023, then jumped by 46.37% to $4.8 million in 2024, then climbed by 17.09% to $5.7 million in 2025, then fell by 23.98% to $4.3 million in 2026.
• Business Quant data shows CAMP's Accumulated Expenses at $4.3 million in Q1 2026, $5.7 million in Q4 2025, and $4.1 million in Q3 2025.